Allergic Rhinitis Epidemiology Forecast 2025-2034

The median worldwide prevalence of allergic rhinitis is estimated to be 18.1%, with most of the studies reporting a rise in rhinitis prevalence over the last decades. Pollen and mites (67.31%), animal dander and pollutants (23.08%), and fungal allergens (21.15%) are considered the most common aero-allergens for allergic rhinitis.

Allergic Rhinitis Epidemiology Forecast Report Coverage

The “Allergic Rhinitis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of allergic rhinitis. It projects the future incidence and prevalence rates of allergic rhinitis across various populations. The study covers age, gender, and type as major determinants of the allergic rhinitis-affected population. The report highlights patterns in the prevalence of allergic rhinitis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of allergic rhinitis in the 8 major markets.

Regions Covered

• The United States
• The United Kingdom
• France
• Italy
• Spain
• Germany
• Japan
• India

Allergic Rhinitis Disease Overview

Allergic rhinitis, also known as hay fever, is a clinical condition linked with a group of symptoms that affect the nose. It occurs when the immune system shows an abnormal reaction to an allergen like pollen, dust, or mold. Hay fever can cause sneezing, runny nose, itchy nose, decreased sense of smell, and sore throat, among others. Allergic rhinitis can be classified into two types: seasonal (occurs at certain times of the year) and perennial (occurs all year).

Allergic Rhinitis: Treatment Overview

Nasal corticosteroid sprays are considered the most effective treatment for allergic rhinitis. It can be used regularly and is safe for both adults and children. Antihistamines, in the form of tablets, syrups, intranasal sprays, and eye drops, are often used to manage the symptoms (sneezing, itchy eyes, and watery eyes) associated with allergic rhinitis. Decongestants are also prescribed to treat stuffy or runny nose.

Epidemiology

The allergic rhinitis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for allergic rhinitis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for allergic rhinitis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to a review published in Clinical and Translational Allergy (2022), the prevalence of rhinitis ranged from 1% to more than 60%, based on the definition and geographical area. Further, the median worldwide prevalence of allergic rhinitis was estimated to be 18.1%.
• Allergic rhinitis affects about 10 to 40% of the general population and is reported as the most common immune disorder globally, according to a systematic review published in Allergies (2023).
• As per Passali, Desiderio et al. (2018), the prevalence of allergic rhinitis is reported to be 15 to 25%. It was also observed that the nasal symptoms of this allergy are more severe in the spring (51.92%) and autumn (28.85%).
• Various meta-analysis studies have suggested that the prevalence of allergic rhinitis is influenced by sex-specific differences, with male predominance observed in childhood and a female predominance seen in adolescents.

Country-wise Allergic Rhinitis Epidemiology

The allergic rhinitis epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of allergic rhinitis differs between countries due to several factors including local environmental conditions, genetic predispositions, exposure to air pollution, and access to healthcare, among others. According to the CDC’s National Center for Health Statistics, approximately 1 out of 3 adults and over 1 in 4 children reported to be affected by a seasonal allergy, food allergy, or eczema in the United States in 2021. Further, the National Health Interview Survey reported that 18.9% of children were affected by allergic rhinitis or hay fever in 2021.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Allergic Rhinitis based on several factors.
• Allergic Rhinitis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of Allergic Rhinitis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of allergic rhinitis epidemiology in the 8 major markets?
• What will be the total number of patients with allergic rhinitis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of allergic rhinitis in the 8 major markets in the historical period?
• Which country will have the highest number of allergic rhinitis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of allergic rhinitis during the forecast period of 2025-2034?
• What are the currently available treatments for allergic rhinitis?
• What are the disease risks, signs, symptoms, and unmet needs of allergic rhinitis?

This product will be delivered within 3-5 business days.